SlideShare a Scribd company logo
EMERGENCY MEDICINE
• SHOCK
• Types of shock
Dr. Chongo Shapi (BSc.HB, MBChB).
Medical Doctor
21 March 2024 1
Dr. Chongo Shapi (BSc. HB, MBChB)
INTRODUCTION
• Circulatory failure resulting in inadequate
organ perfusion. Often defined by Reduced
BP— systolic <90mmHg—or mean arterial
pressure (MAP) <65mmHg—with evidence of
tissue hypoperfusion, eg mottled skin, urine
output (UO) of <0.5mL/kg/h, serum lactate
>2mmol/L.
21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 2
CONT’
• Signs: Reduced GCS/agitation, pallor, cool
peripheries, tachycardia, slow capillary refill,
tachypnoea, oliguria.
• MAP = cardiac output (CO) ≈ systemic vascular
resistance (SVR). CO = stroke volume ≈ heart
rate.
• Therefore, shock can result from inadequate
CO or a loss of SVR, or both.
21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 3
CONT’
Inadequate cardiac output
• Hypovolaemia:
• Bleeding: trauma, ruptured aortic aneurysm, GI bleed.
• Fluid loss: vomiting, burns, ‘third-space’ losses, eg
pancreatitis, heat exhaustion.
• Pump failure:
• Cardiogenic shock, eg ACS, arrhythmias, aortic
dissection, acute valve failure.
• Secondary causes, eg PE, tension pneumothorax,
cardiac tamponade.
21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 4
CONT’
• Peripheral circulatory failure (loss of SVR)
• Sepsis: Infection with any organism can cause
acute vasodilation from inflammatory cytokines.
Gram –ve’s can produce endotoxin, causing
sudden and severe shock but without signs of
infection (fever, Raised WCC). Classically patients
with sepsis are warm & vasodilated, but may be
cold & shut down.
• Other diseases, eg pancreatitis, can give a similar
picture associated with the inflammatory
cascade.
21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 5
CONT’
• Anaphylaxis:
• Neurogenic: Eg spinal cord injury, epidural or
spinal anaesthesia.
• Endocrine failure: Addison’s disease, p836 or
hypothyroidism;
• Other: Drugs, eg anaesthetics,
antihypertensives, cyanide poisoning.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 6
APPROACH
• With shock we are dealing primarily with ‘C ’
so get large-bore IV access ≈2 and check ECG
for rate, rhythm (very fast or very slow will
compromise cardiac output), and signs of
ischaemia.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 7
CONT’
• General review: Cold and clammy suggests
cardiogenic shock or fluid loss. Look for signs
of anaemia or dehydration, eg skin turgor,
postural hypotension? Warm and well
perfused, with bounding pulse points to septic
shock.
• Any features suggestive of anaphylaxis—
history, urticaria, angioedema, wheeze?
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 8
CONT’
• CVS: Usually tachycardic (unless on B-blocker, or in
spinal shock— and hypotensive.
• But in the young and fit, or pregnant women, the
systolic BP may remain normal, although the pulse
pressure will narrow, with up to 30% blood volume
depletion.
• Difference between arms (>20mmHg)—aortic
dissection?
• JVP or central venous pressure: If raised, cardiogenic
shock likely.
• Check abdomen: Any signs of trauma, or aneurysm?
Any evidence of GI bleed?
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 9
MANAGEMENT
• Depends on the type of shock:
a) Septic shock:
b) Anaphylaxis:
c) Cardiogenic shock:
d) Hypovolaemic shock
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 10
HYPOVOLEMIC
SHOCK
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 11
HYPOVOLEMIC SHOCK
• Identify and treat underlying cause. Raise the
legs.
• Give fluid bolus 10–15mL/kg crystalloid via
large peripheral line, if shock improves,
• repeat, titrate to HR (aim <100), BP (aim SBP
>90) and UO (aim >0.5mL/kg/h).
• If no improvement after 2 boluses, consider
referral to ICU
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 12
HAEMORRHAGIC
SHOCK
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 13
HAEMORRHAGIC SHOCK
• Stop bleeding if possible. Identification of grade is
significant.
• If still shocked despite 2L crystalloid or present
with class III/IV shock then crossmatch blood
(request O Rh–ve in an emergency).
• Give FFP with red cells (1 : 1 ratio); aim for
platelets >100 and fibrinogen >1 (guided by
results, but eg 1 pool of platelets and 2 pools of
cryoprecipitate per 6–8 units of red cells).
• Consider tranexamic acid 2g IV. Discuss with
haematology early.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 14
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 15
SHOCK
SEPSIS
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 16
SEPSIS
• Sepsis Life-threatening organ dysfunction caused
by a dysregulated host response to infection.
• Sepsis is a major killer. There are >150 000 cases
of sepsis in the UK each year resulting in >44 000
deaths, and much morbidity.
• Septic shock Sepsis in combination with:
a) EITHER lactate >2mmol/L despite adequate
fluid resuscitation
b) OR the patient is requiring vasopressors to
maintain MAP ≥65mmHg.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 17
CONT’
• Many sepsis-related deaths could be prevented with earlier
treatment. Often, the key failure in sepsis management is not
recognizing sepsis in time.
• Early warning scores help identify inpatients who are becoming
septic.
• Have a low threshold for assessing for sepsis if:
a) The patient has communication difficulties: limited English;
limited verbal communication or cognitive impairment
b) The patient is immunosuppressed, on chemotherapy, or an IV
drug user
c) The patient recently had surgery or is pregnant/recently gave birth
d) The patient has indwelling lines/other foreign material.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 18
ASSESSING RISK IN SEPSIS
MODERATE TO HIGH RISK
CRITERIA
• Reports of altered mental
state or acute deterioration
in functional status
• Respiratory rate (RR) 21–24
• Systolic blood pressure
(SBP) 91–100mmHg
• Heart rate 91–130bpm or
new arrhythmia.
• Urine output: nil for 12–
18h; 0.5–1.0mL/kg/h if
catheterized
HIGH RISK CRITERIA
• Objective evidence of
altered mental state
• RR>24; new requirement
for FiO2 >40% to keep sats
>92% (>88% in COPD)
• SBP <90 or >40mmHg less
than baseline
• Heart rate >130bpm
• Urine output: nil for 18h;
<0.5mL/kg/h if catheterized
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 19
CONT’
• Local signs of infection,
incl. redness, swelling, or
discharge around wound
• Rigors, or temperature
<36°C
• Impaired immunity
(illness or drugs)
• Recent
surgery/trauma/invasive
procedure
• Mottled, ashen, or
cyanotic skin. Non-
blanching rash
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 20
CONT’
• High risk: At least one high-risk criterion OR at
least two moderate- to high-risk criteria with
AKI or LACTATE >2.
• Moderate to high risk: At least one moderate-
to high-risk criterion.
• Low risk: No moderate- or high-risk criteria.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 21
ACUTE MANAGEMENT IN SEPSIS
• Early recognition and treatment is key.
• Antibiotics: These should be broad spectrum and start
within 1h. Consider covering for non-bacterial
microbes, eg give aciclovir if HSV encephalitis is
suspected.
• Fluids: Give within 1h if high risk with SBP <90, AKI, or
lactate >2 (consider if <2).
❑Give 500mL boluses of crystalloids with 130–
154mmol/L sodium (eg 0.9% saline) over 15mins.
Caution in heart failure.
❑ If no improvement after two boluses, speak with a
senior. (Possible use of inotropes)
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 22
CONT’
• Oxygen: Give oxygen as required for target saturations.
These will be 94–98% (or 88–92% if the patient is at
risk of CO2 retention, eg in severe COPD).
• Critical care review: Speak with critical care early if
intensive care support (eg inotropes, ventilation,
haemofiltration, intensive monitoring) may be
required.
• Surgical involvement: Eg emergency wound
debridement.
• Manage acute complications: Shock, AKI, DIC, ARDS,
arrhythmias etc (may spontaneously resolve when
sepsis improves).
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 23
SHOCK
ANAPHYLACTIC SHOCK
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 24
ANAPHYLACTIC SHOCK
• Type I IgE-mediated hypersensitivity reaction.
Release of histamine and other agents causes:
capillary leak; wheeze; cyanosis; oedema
(larynx, lids, tongue, lips); urticaria.
• More common in atopic individuals. An
anaphylactoid reaction results from direct
release of mediators from inflammatory cells,
without involving antibodies, usually in
response to a drug, eg acetylcysteine.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 25
CONT’
• Examples of precipitants:
a) Drugs, eg penicillin, and contrast media in
radiology.
b) Latex.
c) Stings, eggs, fish, peanuts, strawberries,
semen (rare).
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 26
CONT’
• Signs and symptoms
a) Itching, sweating, diarrhoea and vomiting,
erythema, urticaria, oedema.
b) Wheeze, laryngeal obstruction, cyanosis.
Tachycardia, hypotension.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 27
MANAGEMENT
• Secure the airway—give 100% O2 but Intubate if
respiratory obstruction imminent.
• Remove the cause; raising the feet may help
restore the circulation.
• Give adrenaline IM 0.5mg (ie 0.5mL of 1:1000).
Repeat every 5min, if needed as guided by BP,
pulse, and respiratory function, until better
• Give Chlorphenamine 10mg IV and
hydrocortisone 200mg IV
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 28
CONT’
• IVI (0.9% saline, eg 500mL over ¼h; up to 2L
may be needed) Titrate against blood
pressure.
• If wheeze, treat for asthma. May require
ventilatory support.
• If still hypotensive, admission to ICU and an
IVI of adrenaline may be needed ±
aminophylline and nebulized salbutamol
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 29
CONT’
• When stable, admit to ward. Monitor ECG
• Measure serum tryptase 1–6h after suspected
anaphylaxis
• Continue chlorphenamine 4mg/6h PO if itching
• Suggest a ‘MedicAlert’ bracelet naming the
culprit allergen
• Teach about self-injected adrenaline (eg 0.3mg,
Epipen®) to prevent a fatal attack
• Skin-prick tests showing specific IgE help identify
allergens to avoid
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 30
CONT’
• Adrenaline (=epinephrine) is given IM and
NOT IV unless the patient is severely ill, or has
no pulse. The IV dose is different:
100mcg/min—titrating with the response.
• This is 0.5mL of 1 : 10 000 solution IV per
minute. Stop as soon as a response has been
obtained.
• If on a B-blocker, consider salbutamol IV in
place of adrenaline.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 31
THE END!
• Reference as per Oxford Clinical Medicine.
22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 32
Thanks
21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 33

More Related Content

PPTX
sepsis.pptxMNGHGBDHSB KJHDGBSHVCJB KJDCGHBYUHFB SDJKFHDUJ
PPTX
Shock.pptx
PPTX
SHOCK .pptx
PPTX
PPT
Shock states in children
PPTX
SHOCK: Types, investigations, management
sepsis.pptxMNGHGBDHSB KJHDGBSHVCJB KJDCGHBYUHFB SDJKFHDUJ
Shock.pptx
SHOCK .pptx
Shock states in children
SHOCK: Types, investigations, management

Similar to Shock (General Overview)... By Shapi.pdf (20)

PPT
5. Shock (Edited) (2).ppt general concept
PPTX
SEMINAR SURGERY approach for shock and its mgt
PPTX
SHOCK IN CHILDREN.pptx
PPT
SHOCK AND ITS COMPLICATIONS.ppt
PPTX
Shock (2).pptx
PPTX
shock
PPT
PPTX
Approach to Shock for Seminar Jan.2024.pptx
PPT
Understanding Shock: Recognition and Resuscitation
PPTX
Approach to a patient in shock
PPTX
Approach to shock
PPTX
shock - definition, diagnosis, pathophysiology, classification, management
PPTX
shock for dental and medical students .pptx
PDF
distributiveshock-210608073854 (1).pdf
PPTX
Distributive shock
PPT
Archer Critical care for USMLE Step 3
PPTX
Shock pathophysiology and causes
PPT
55.ppt
5. Shock (Edited) (2).ppt general concept
SEMINAR SURGERY approach for shock and its mgt
SHOCK IN CHILDREN.pptx
SHOCK AND ITS COMPLICATIONS.ppt
Shock (2).pptx
shock
Approach to Shock for Seminar Jan.2024.pptx
Understanding Shock: Recognition and Resuscitation
Approach to a patient in shock
Approach to shock
shock - definition, diagnosis, pathophysiology, classification, management
shock for dental and medical students .pptx
distributiveshock-210608073854 (1).pdf
Distributive shock
Archer Critical care for USMLE Step 3
Shock pathophysiology and causes
55.ppt
Ad

More from Shapi. MD (20)

PDF
Hearing loss (Ear Nose and Throat)... By Shapi.pdf
PDF
Allergic Rhinitis( Ear Nose and Throat).... By Shapi.pdf
PDF
Otitis Media and Otitis Externa... By Shapi.pdf
PDF
HERPES ZOSTER OTICUS (Ramsey Hunt's Syndrome).. By Shapi.pdf
PDF
Bronchiectasis (Respiratory Medicine).....By Shapi.pdf
PDF
Introduction to GI Medicine.... By Shapi.pdf
PDF
Hypoglycemia (As in the ER)...... By Shapi.pdf
PDF
Common Presentations (As in the ER)... By Shapi.pdf
PDF
Biochemistry of Carbohydrates.. By Shapi.pdf
PDF
Anatomy of the GLUTEAL REGION........ By Shapi.pdf
PDF
BioChemistry of Lipids......... By Shapi.
PDF
Acute Coronary Syndromes and Angina.. By Shapi.
PDF
Pneumonia (Community Aqcuired and Hospital Aqcuired).. By Shapi
PDF
Development Urinary system by Shapi. MD.pdf
PDF
DEVELOPMENT OF RESPIRATORY SYSTEM by Shapi. MD.pdf
PDF
Gametogenesis 2nd.pdf
PDF
Bilaminar and trilaminar discs formation.pdf
PDF
Gametogenesis and Pre-ebryonic life by Shapi. MDpdf
PDF
NOTOCHORD, NEURULATION AND NTDs by Shapi. MD.pdf
PDF
Congenital Anomalies.pdf
Hearing loss (Ear Nose and Throat)... By Shapi.pdf
Allergic Rhinitis( Ear Nose and Throat).... By Shapi.pdf
Otitis Media and Otitis Externa... By Shapi.pdf
HERPES ZOSTER OTICUS (Ramsey Hunt's Syndrome).. By Shapi.pdf
Bronchiectasis (Respiratory Medicine).....By Shapi.pdf
Introduction to GI Medicine.... By Shapi.pdf
Hypoglycemia (As in the ER)...... By Shapi.pdf
Common Presentations (As in the ER)... By Shapi.pdf
Biochemistry of Carbohydrates.. By Shapi.pdf
Anatomy of the GLUTEAL REGION........ By Shapi.pdf
BioChemistry of Lipids......... By Shapi.
Acute Coronary Syndromes and Angina.. By Shapi.
Pneumonia (Community Aqcuired and Hospital Aqcuired).. By Shapi
Development Urinary system by Shapi. MD.pdf
DEVELOPMENT OF RESPIRATORY SYSTEM by Shapi. MD.pdf
Gametogenesis 2nd.pdf
Bilaminar and trilaminar discs formation.pdf
Gametogenesis and Pre-ebryonic life by Shapi. MDpdf
NOTOCHORD, NEURULATION AND NTDs by Shapi. MD.pdf
Congenital Anomalies.pdf
Ad

Recently uploaded (20)

PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PDF
Complications of Minimal Access Surgery at WLH
PPTX
Cell Types and Its function , kingdom of life
PPTX
Tissue processing ( HISTOPATHOLOGICAL TECHNIQUE
PDF
GENETICS IN BIOLOGY IN SECONDARY LEVEL FORM 3
PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PDF
O5-L3 Freight Transport Ops (International) V1.pdf
PDF
Weekly quiz Compilation Jan -July 25.pdf
DOC
Soft-furnishing-By-Architect-A.F.M.Mohiuddin-Akhand.doc
PPTX
human mycosis Human fungal infections are called human mycosis..pptx
PDF
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
PPTX
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
PPTX
GDM (1) (1).pptx small presentation for students
PDF
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PPTX
Final Presentation General Medicine 03-08-2024.pptx
PPTX
Pharma ospi slides which help in ospi learning
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
PDF
RTP_AR_KS1_Tutor's Guide_English [FOR REPRODUCTION].pdf
PPTX
Microbial diseases, their pathogenesis and prophylaxis
STATICS OF THE RIGID BODIES Hibbelers.pdf
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
Complications of Minimal Access Surgery at WLH
Cell Types and Its function , kingdom of life
Tissue processing ( HISTOPATHOLOGICAL TECHNIQUE
GENETICS IN BIOLOGY IN SECONDARY LEVEL FORM 3
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
O5-L3 Freight Transport Ops (International) V1.pdf
Weekly quiz Compilation Jan -July 25.pdf
Soft-furnishing-By-Architect-A.F.M.Mohiuddin-Akhand.doc
human mycosis Human fungal infections are called human mycosis..pptx
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
GDM (1) (1).pptx small presentation for students
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
Final Presentation General Medicine 03-08-2024.pptx
Pharma ospi slides which help in ospi learning
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
RTP_AR_KS1_Tutor's Guide_English [FOR REPRODUCTION].pdf
Microbial diseases, their pathogenesis and prophylaxis

Shock (General Overview)... By Shapi.pdf

  • 1. EMERGENCY MEDICINE • SHOCK • Types of shock Dr. Chongo Shapi (BSc.HB, MBChB). Medical Doctor 21 March 2024 1 Dr. Chongo Shapi (BSc. HB, MBChB)
  • 2. INTRODUCTION • Circulatory failure resulting in inadequate organ perfusion. Often defined by Reduced BP— systolic <90mmHg—or mean arterial pressure (MAP) <65mmHg—with evidence of tissue hypoperfusion, eg mottled skin, urine output (UO) of <0.5mL/kg/h, serum lactate >2mmol/L. 21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 2
  • 3. CONT’ • Signs: Reduced GCS/agitation, pallor, cool peripheries, tachycardia, slow capillary refill, tachypnoea, oliguria. • MAP = cardiac output (CO) ≈ systemic vascular resistance (SVR). CO = stroke volume ≈ heart rate. • Therefore, shock can result from inadequate CO or a loss of SVR, or both. 21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 3
  • 4. CONT’ Inadequate cardiac output • Hypovolaemia: • Bleeding: trauma, ruptured aortic aneurysm, GI bleed. • Fluid loss: vomiting, burns, ‘third-space’ losses, eg pancreatitis, heat exhaustion. • Pump failure: • Cardiogenic shock, eg ACS, arrhythmias, aortic dissection, acute valve failure. • Secondary causes, eg PE, tension pneumothorax, cardiac tamponade. 21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 4
  • 5. CONT’ • Peripheral circulatory failure (loss of SVR) • Sepsis: Infection with any organism can cause acute vasodilation from inflammatory cytokines. Gram –ve’s can produce endotoxin, causing sudden and severe shock but without signs of infection (fever, Raised WCC). Classically patients with sepsis are warm & vasodilated, but may be cold & shut down. • Other diseases, eg pancreatitis, can give a similar picture associated with the inflammatory cascade. 21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 5
  • 6. CONT’ • Anaphylaxis: • Neurogenic: Eg spinal cord injury, epidural or spinal anaesthesia. • Endocrine failure: Addison’s disease, p836 or hypothyroidism; • Other: Drugs, eg anaesthetics, antihypertensives, cyanide poisoning. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 6
  • 7. APPROACH • With shock we are dealing primarily with ‘C ’ so get large-bore IV access ≈2 and check ECG for rate, rhythm (very fast or very slow will compromise cardiac output), and signs of ischaemia. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 7
  • 8. CONT’ • General review: Cold and clammy suggests cardiogenic shock or fluid loss. Look for signs of anaemia or dehydration, eg skin turgor, postural hypotension? Warm and well perfused, with bounding pulse points to septic shock. • Any features suggestive of anaphylaxis— history, urticaria, angioedema, wheeze? 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 8
  • 9. CONT’ • CVS: Usually tachycardic (unless on B-blocker, or in spinal shock— and hypotensive. • But in the young and fit, or pregnant women, the systolic BP may remain normal, although the pulse pressure will narrow, with up to 30% blood volume depletion. • Difference between arms (>20mmHg)—aortic dissection? • JVP or central venous pressure: If raised, cardiogenic shock likely. • Check abdomen: Any signs of trauma, or aneurysm? Any evidence of GI bleed? 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 9
  • 10. MANAGEMENT • Depends on the type of shock: a) Septic shock: b) Anaphylaxis: c) Cardiogenic shock: d) Hypovolaemic shock 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 10
  • 11. HYPOVOLEMIC SHOCK 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 11
  • 12. HYPOVOLEMIC SHOCK • Identify and treat underlying cause. Raise the legs. • Give fluid bolus 10–15mL/kg crystalloid via large peripheral line, if shock improves, • repeat, titrate to HR (aim <100), BP (aim SBP >90) and UO (aim >0.5mL/kg/h). • If no improvement after 2 boluses, consider referral to ICU 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 12
  • 13. HAEMORRHAGIC SHOCK 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 13
  • 14. HAEMORRHAGIC SHOCK • Stop bleeding if possible. Identification of grade is significant. • If still shocked despite 2L crystalloid or present with class III/IV shock then crossmatch blood (request O Rh–ve in an emergency). • Give FFP with red cells (1 : 1 ratio); aim for platelets >100 and fibrinogen >1 (guided by results, but eg 1 pool of platelets and 2 pools of cryoprecipitate per 6–8 units of red cells). • Consider tranexamic acid 2g IV. Discuss with haematology early. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 14
  • 15. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 15
  • 16. SHOCK SEPSIS 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 16
  • 17. SEPSIS • Sepsis Life-threatening organ dysfunction caused by a dysregulated host response to infection. • Sepsis is a major killer. There are >150 000 cases of sepsis in the UK each year resulting in >44 000 deaths, and much morbidity. • Septic shock Sepsis in combination with: a) EITHER lactate >2mmol/L despite adequate fluid resuscitation b) OR the patient is requiring vasopressors to maintain MAP ≥65mmHg. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 17
  • 18. CONT’ • Many sepsis-related deaths could be prevented with earlier treatment. Often, the key failure in sepsis management is not recognizing sepsis in time. • Early warning scores help identify inpatients who are becoming septic. • Have a low threshold for assessing for sepsis if: a) The patient has communication difficulties: limited English; limited verbal communication or cognitive impairment b) The patient is immunosuppressed, on chemotherapy, or an IV drug user c) The patient recently had surgery or is pregnant/recently gave birth d) The patient has indwelling lines/other foreign material. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 18
  • 19. ASSESSING RISK IN SEPSIS MODERATE TO HIGH RISK CRITERIA • Reports of altered mental state or acute deterioration in functional status • Respiratory rate (RR) 21–24 • Systolic blood pressure (SBP) 91–100mmHg • Heart rate 91–130bpm or new arrhythmia. • Urine output: nil for 12– 18h; 0.5–1.0mL/kg/h if catheterized HIGH RISK CRITERIA • Objective evidence of altered mental state • RR>24; new requirement for FiO2 >40% to keep sats >92% (>88% in COPD) • SBP <90 or >40mmHg less than baseline • Heart rate >130bpm • Urine output: nil for 18h; <0.5mL/kg/h if catheterized 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 19
  • 20. CONT’ • Local signs of infection, incl. redness, swelling, or discharge around wound • Rigors, or temperature <36°C • Impaired immunity (illness or drugs) • Recent surgery/trauma/invasive procedure • Mottled, ashen, or cyanotic skin. Non- blanching rash 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 20
  • 21. CONT’ • High risk: At least one high-risk criterion OR at least two moderate- to high-risk criteria with AKI or LACTATE >2. • Moderate to high risk: At least one moderate- to high-risk criterion. • Low risk: No moderate- or high-risk criteria. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 21
  • 22. ACUTE MANAGEMENT IN SEPSIS • Early recognition and treatment is key. • Antibiotics: These should be broad spectrum and start within 1h. Consider covering for non-bacterial microbes, eg give aciclovir if HSV encephalitis is suspected. • Fluids: Give within 1h if high risk with SBP <90, AKI, or lactate >2 (consider if <2). ❑Give 500mL boluses of crystalloids with 130– 154mmol/L sodium (eg 0.9% saline) over 15mins. Caution in heart failure. ❑ If no improvement after two boluses, speak with a senior. (Possible use of inotropes) 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 22
  • 23. CONT’ • Oxygen: Give oxygen as required for target saturations. These will be 94–98% (or 88–92% if the patient is at risk of CO2 retention, eg in severe COPD). • Critical care review: Speak with critical care early if intensive care support (eg inotropes, ventilation, haemofiltration, intensive monitoring) may be required. • Surgical involvement: Eg emergency wound debridement. • Manage acute complications: Shock, AKI, DIC, ARDS, arrhythmias etc (may spontaneously resolve when sepsis improves). 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 23
  • 24. SHOCK ANAPHYLACTIC SHOCK 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 24
  • 25. ANAPHYLACTIC SHOCK • Type I IgE-mediated hypersensitivity reaction. Release of histamine and other agents causes: capillary leak; wheeze; cyanosis; oedema (larynx, lids, tongue, lips); urticaria. • More common in atopic individuals. An anaphylactoid reaction results from direct release of mediators from inflammatory cells, without involving antibodies, usually in response to a drug, eg acetylcysteine. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 25
  • 26. CONT’ • Examples of precipitants: a) Drugs, eg penicillin, and contrast media in radiology. b) Latex. c) Stings, eggs, fish, peanuts, strawberries, semen (rare). 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 26
  • 27. CONT’ • Signs and symptoms a) Itching, sweating, diarrhoea and vomiting, erythema, urticaria, oedema. b) Wheeze, laryngeal obstruction, cyanosis. Tachycardia, hypotension. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 27
  • 28. MANAGEMENT • Secure the airway—give 100% O2 but Intubate if respiratory obstruction imminent. • Remove the cause; raising the feet may help restore the circulation. • Give adrenaline IM 0.5mg (ie 0.5mL of 1:1000). Repeat every 5min, if needed as guided by BP, pulse, and respiratory function, until better • Give Chlorphenamine 10mg IV and hydrocortisone 200mg IV 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 28
  • 29. CONT’ • IVI (0.9% saline, eg 500mL over ¼h; up to 2L may be needed) Titrate against blood pressure. • If wheeze, treat for asthma. May require ventilatory support. • If still hypotensive, admission to ICU and an IVI of adrenaline may be needed ± aminophylline and nebulized salbutamol 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 29
  • 30. CONT’ • When stable, admit to ward. Monitor ECG • Measure serum tryptase 1–6h after suspected anaphylaxis • Continue chlorphenamine 4mg/6h PO if itching • Suggest a ‘MedicAlert’ bracelet naming the culprit allergen • Teach about self-injected adrenaline (eg 0.3mg, Epipen®) to prevent a fatal attack • Skin-prick tests showing specific IgE help identify allergens to avoid 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 30
  • 31. CONT’ • Adrenaline (=epinephrine) is given IM and NOT IV unless the patient is severely ill, or has no pulse. The IV dose is different: 100mcg/min—titrating with the response. • This is 0.5mL of 1 : 10 000 solution IV per minute. Stop as soon as a response has been obtained. • If on a B-blocker, consider salbutamol IV in place of adrenaline. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 31
  • 32. THE END! • Reference as per Oxford Clinical Medicine. 22 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 32
  • 33. Thanks 21 March 2024 Dr. Chongo Shapi (BSc. HB, MBChB) 33